meibomask® is for professionals that want to focus on the unique benefits of our LM® LLLT technology for the treatment of most ocular surface diseases. Meibomask® packs a punch when it comes to photobiomodulation technology—enabling patients and operators to benefit from everything Light Modulation® Low Level Light Therapy (LM® LLLT) has to offer:
Complete + Direct Treatment
meibomask® enables a full therapy, covering both lower and upper eyelids, to grant maximum efficacy in treating Dry Eye Disease (DED) induced by Meibomian Glands Dysfunction (MGD), Chalazion, Blepharitis, Sjögren’s Syndrome, Post-blepharoplasty.
meibomask® and LM® LLLT provide patients with an entirely painless therapy. Near-infrared light is emitted on the skin at a medically-certified wavelength, generating endogenous heating by stimulating cells’ ATP production.
For patients, this means immediate relief, just 15 minutes after the therapy—for operators, it means delivering greater value to patients, with much less effort.
No training needed, no set-up time. It just works.